Physician profile
Brittney Strunk
NPI 1467853549
$1,655.82
in general payments reported to CMS, 2019-2025
18 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $339 · 2022: $341 · 2023: $249 · 2024: $394 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $957 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $957.39 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $384.96 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $265.90 | 2021-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $218.20 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $209.97 | 2021-2024 | Xifaxan |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $84.55 | 2024-2025 | Caplyta |
| Lilly USA, LLC | $74.90 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Averitas Pharma INC. | $73.11 | 2025 | Qutenza |
| Bayer Healthcare Pharmaceuticals INC. | $69.36 | 2022-2025 | |
| Exact Sciences Corporation | $62.75 | 2024 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $47.86 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $32.18 | 2024-2025 | Farxiga |
| Otsuka America Pharmaceutical, INC. | $25.50 | 2023 | Rexulti |
| Axsome Therapeutics, INC. | $22.43 | 2025 | Auvelity |
| Lundbeck LLC | $19.93 | 2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.85 | 2025 | Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $17.84 | 2024 | Voquezna |
| Optinose US, INC. | $15.09 | 2024 | |
| Alkermes, INC. | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittney Strunk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.